Kiadis Pharma NV (FRA:K3P) Other Stockholders Equity : €-1.24 Mil (As of Dec. 2020)

View and export this data going back to 2015. Start your Free Trial

What is Kiadis Pharma NV Other Stockholders Equity?

Kiadis Pharma NV's Other Stockholders Equity for the quarter that ended in Dec. 2020 was €-1.24 Mil.

Kiadis Pharma NV's quarterly Other Stockholders Equity increased from Dec. 2019 (€0.26 Mil) to Jun. 2020 (€1.03 Mil) but then declined from Jun. 2020 (€1.03 Mil) to Dec. 2020 (€-1.24 Mil).

Kiadis Pharma NV's annual Other Stockholders Equity declined from Dec. 2018 (€0.69 Mil) to Dec. 2019 (€0.26 Mil) and declined from Dec. 2019 (€0.26 Mil) to Dec. 2020 (€-1.24 Mil).

Kiadis Pharma NV Other Stockholders Equity Historical Data

The historical data trend for Kiadis Pharma NV's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kiadis Pharma NV Other Stockholders Equity Chart

Kiadis Pharma NV Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Other Stockholders Equity

Get a 7-Day Free Trial

0.31

1.57

0.69

0.26

-1.24

Kiadis Pharma NV Semi-Annual Data
	Dec12	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20
Other Stockholders Equity	Get a 7-Day Free Trial											0.69	0.28	0.26	1.03	-1.24

Kiadis Pharma NV Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Kiadis Pharma NV Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Kiadis Pharma NV's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Kiadis Pharma NV (FRA:K3P) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kiadis Pharma NV (FRA:K3P) » Definitions » Other Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

Paasheuvelweg 25A, Amsterdam, NLD, 1105 BP

Website

https://www.kiadis.com

Kiadis Pharma NV is a Netherlands based clinical-stage biopharmaceutical company. It is focused on research, development, and commercialization of cell-based immunotherapy products for the treatment of blood cancers and inherited blood disorders. The company's product pipeline includes K-NK002, K-NK003, K-NK00X, and others.

Kiadis Pharma NV (FRA:K3P) Headlines

No Headlines